Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

STRATA Skin Sciences (SSKN) Research & Development (2016 - 2025)

STRATA Skin Sciences' Research & Development history spans 14 years, with the latest figure at $67000.0 for Q4 2025.

  • On a quarterly basis, Research & Development fell 66.5% to $67000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $421000.0, a 52.32% decrease, with the full-year FY2025 number at $421000.0, down 52.32% from a year prior.
  • Research & Development hit $67000.0 in Q4 2025 for STRATA Skin Sciences, down from $172000.0 in the prior quarter.
  • Over the last five years, Research & Development for SSKN hit a ceiling of $441000.0 in Q4 2022 and a floor of $67000.0 in Q4 2025.
  • Historically, Research & Development has averaged $254200.0 across 5 years, with a median of $242000.0 in 2024.
  • Biggest five-year swings in Research & Development: soared 93.25% in 2023 and later plummeted 66.5% in 2025.
  • Tracing SSKN's Research & Development over 5 years: stood at $276000.0 in 2021, then surged by 59.78% to $441000.0 in 2022, then decreased by 13.83% to $380000.0 in 2023, then crashed by 47.37% to $200000.0 in 2024, then plummeted by 66.5% to $67000.0 in 2025.
  • Business Quant data shows Research & Development for SSKN at $67000.0 in Q4 2025, $172000.0 in Q3 2025, and $86000.0 in Q2 2025.